Abstract
Background Chronic Fatigue is a major clinical unmet need among patients with Rheumatoid Arthritis (RA). Current therapies are limited to non-pharmacological interventions, such as personalised exercise programmes (PEP) and cognitive behavioural approaches (CBA), however, still most patients continue to report severe fatigue. To inform more effective therapies, we conducted an MRI brain study of PEP and CBA, nested within a randomised controlled trial (RCT), to identify their neurobiological mechanisms of fatigue reduction in RA.
Methods A sub-group of RA subjects (n=90), participating in a RCT of PEP/CBA for fatigue, undertook a multi-modal MRI brain scan following randomisation to either usual care (UC) alone or in addition to PEP/CBA, and again after the intervention (6 months). Brain regional volumetric, functional, and structural connectivity indices were curated and then computed employing a causal analysis framework. The primary outcome was fatigue improvement (Chalder Fatigue Scale).
Findings Several structural and functional connections were identified as mediators of fatigue improvement in both PEP and CBA compared to UC. PEP had a more pronounced effect on functional connectivity than CBA, however, structural connectivity between the left isthmus cingulate cortex (L-ICC) and left paracentral lobule (L-PCL) was shared and the size of mediation effect ranked highly for both PEP/CBA (ßAverage=-0·46, SD 0·61; ßAverage=-0·32, SD 0·47, respectively).
Interpretation The structural connection between the L-ICC and L-PCL appears to be a dominant mechanism for how both PEP/CBA reduces fatigue among RA patients. This supports its potential as a substrate of fatigue neurobiology and a putative candidate for future targeting.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Trial registration number NCT03248518
Clinical Protocols
https://clinicaltrials.gov/study/NCT03248518
Funding Statement
This study was funded by the Chief Scientist Office (TCS/17/14) and Versus Arthritis (22092).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval has been granted by Wales REC 7 (17/WA/0065). Results of this study will be disseminated through presentation at scientific conferences and in scientific journal. A lay summary of the results will be sent to participants.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Abbreviations: CBA = Cognitive Behavioural Approach; DAN = Dorsal Attention Network; DMN = Default Mode Network; DTI = Diffusion Tensor Imaging; FA = Fractional Anisotropy, fcMRI = Functional Connectivity; MRI = Magnetic Resonance Imaging; PEP = Personalised Exercise Programme; RA = Rheumatoid Arthritis; RCT = Randomised Controlled Trial; SMN = Somatosensory Network; tDCS = Transcranial Direct Current Stimulation; Transcranial Magnetic Stimulation = TMS; UC = Usual Care.
